MEF2A and neoplasm: The most significant CRISPRi screened enhancer E_349 interacts with MEF2A and LRRC28 instead of its designed target IGF1R, which implies that HRR-associated enhancers could modulate multiple uncharacterized melanoma cancer genes for tumor survival.